Literature DB >> 14617518

Biosynthesized matrix provides a key role for survival signaling in bronchial epithelial cells.

Sam J Wadsworth1, Anette M Freyer, Randolph L Corteling, Ian P Hall.   

Abstract

The extracellular matrix (ECM) influences a variety of cellular functions, including survival, adhesion molecule expression, differentiation, and migration. The ECM composition of the epithelial basement membrane is altered in asthmatics. In this study, we elucidate the major survival signals received by bronchial epithelial cells in vitro by studying the effects of a variety of ECM factors and soluble growth factors on bronchial epithelial cell survival. Our findings indicate that the insulin family of soluble growth factors provides important survival signals but also that adhesion to ECM is a crucial determinant of bronchial epithelial cell survival. In the BEAS-2B bronchial epithelial cell line, collagens I and IV, laminin, fibronectin, and vitronectin provide significant levels of protection from apoptosis. Tenascin-C has no effect, whereas elastin and collagen V increase apoptosis to above control levels. BEAS-2B cells secrete their own biosynthesized matrix (BSM), which also provides rescue from apoptosis. Protection by collagen I, fibronectin, and vitronectin was found to be via an RGD domain. Laminin-, collagen IV-, and BSM-mediated survival is not RGD dependent. Primary bronchial epithelial cells exhibit a similar pattern of apoptosis rescue to the BEAS-2B cell line, although we did not observe any vitronectin-mediated protection in the primary cells. These data indicate that bronchial epithelial cell survival is dependent both on soluble growth factors and on a variety of ECM-derived signals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14617518     DOI: 10.1152/ajplung.00217.2003

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  7 in total

1.  Inter-alpha-trypsin inhibitor promotes bronchial epithelial repair after injury through vitronectin binding.

Authors:  Jennifer E Adair; Vandy Stober; Mack Sobhany; Lisheng Zhuo; John D Roberts; Masahiko Negishi; Koji Kimata; Stavros Garantziotis
Journal:  J Biol Chem       Date:  2009-04-24       Impact factor: 5.157

2.  Alveolar type II cells from ethanol-fed rats produce a fibronectin-enriched extracellular matrix that promotes monocyte activation.

Authors:  Lou Ann S Brown; Jeffrey D Ritzenthaler; David M Guidot; Jesse Roman
Journal:  Alcohol       Date:  2007-08       Impact factor: 2.405

3.  Rhinovirus infection induces cytotoxicity and delays wound healing in bronchial epithelial cells.

Authors:  Apostolos Bossios; Stelios Psarras; Dimitrios Gourgiotis; Chrysanthi L Skevaki; Andreas G Constantopoulos; Photini Saxoni-Papageorgiou; Nikolaos G Papadopoulos
Journal:  Respir Res       Date:  2005-10-10

4.  Differentiation of human colon tissue in culture: Effects of calcium on trans-epithelial electrical resistance and tissue cohesive properties.

Authors:  Shannon D McClintock; Durga Attili; Michael K Dame; Aliah Richter; Sabrina S Silvestri; Maliha M Berner; Margaret S Bohm; Kateryna Karpoff; Caroline L McCarthy; Jason R Spence; James Varani; Muhammad N Aslam
Journal:  PLoS One       Date:  2020-03-05       Impact factor: 3.240

5.  Vitronectin improves cell survival after radiation injury in human umbilical vein endothelial cells.

Authors:  Masaharu Hazawa; Takeshi Yasuda; Katsuko Noshiro; Ai Saotome-Nakamura; Tomoko Fukuzaki; Yuichi Michikawa; Takaya Gotoh; Katsushi Tajima
Journal:  FEBS Open Bio       Date:  2012-10-17       Impact factor: 2.693

6.  Clara cell adhesion and migration to extracellular matrix.

Authors:  Jeffrey J Atkinson; Tracy L Adair-Kirk; Diane G Kelley; Daphne Demello; Robert M Senior
Journal:  Respir Res       Date:  2008-01-07

7.  Extra-cellular matrix proteins induce matrix metalloproteinase-1 (MMP-1) activity and increase airway smooth muscle contraction in asthma.

Authors:  Natasha K Rogers; Debbie Clements; Arundhati Dongre; Tim W Harrison; Dominic Shaw; Simon R Johnson
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.